A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))
Part of paid clinical trials in Coral Gables, Florida.
- Sponsor
- Pfizer
- Study ID
- NCT02237729
- Phase
- PHASE1
- Status
- Completed
Conditions
- Healthy Subjects
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 45 Years
- Healthy Volunteers
- Accepted
Interventions
- PF-06410293 — BIOLOGICALPF-06410293 will be administered as a single 40 mg, subcutaneous dose
- Adalimumab-US — BIOLOGICALAdalimumab-US will be administered as a single 40 mg, subcutaneous dose
- Adalimumab-EU — BIOLOGICALAdalimumab-EU will be administered as a single 40 mg, subcutaneous dose
Study Details
This is a Phase 1, double blind (sponsor open), randomized (1:1:1), parallel group, 3 arm, single dose comparative PK study of adalimumab Pfizer and adalimumab sourced from the US and EU administered subcutaneously (SC) to healthy male and female volunteers
Key Dates
- Start date
- Sep 30, 2014
- Status verified
- Apr 2015
- Primary completion
- Mar 31, 2015
- Completion
- Mar 31, 2015
Study Design
- Enrollment
- 362 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: PF-06410293
- Active Comparator: Adalimumab-US
- Active Comparator: Adalimumab-EUAdalimumab-EU will be administered as a single 40 mg, subcutaneous dose
Primary Outcome Measure
maximal serum concentration (Cmax) [ Time Frame: Day 1 - Day 50 ]
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| De La Pedraja Radiology Associates | Coral Gables | Florida | 33134 | - |
| SeaView Jacksonville | Jacksonville | Florida | 32256 | - |
| SeaView Reseach Screening Office | Miami | Florida | 33134 | - |
| SeaView Research, Inc. | Miami | Florida | 33126 | - |
| SeaView Research, Inc. (Screening Office) | Miami | Florida | 33134 | - |
| Vince & Associates Clinical Research, Inc. | Overland Park | Kansas | 66211 | - |
| Vince & Associates Clinical Research, Inc. | Overland Park | Kansas | 66212 | - |
| Prism Research, LLC | Saint Paul | Minnesota | 55114 | - |
Find similar trials in Coral Gables, FL
Related Studies
- High Frequency Stimulation to Improve Cognition, Mobility, and Affect in Individuals With and Without Subjective Cognitive DeclineNot Yet Recruiting · University of Florida · Gainesville, Florida
- Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)Recruiting · National Institute of Dental and Craniofacial Research (NIDCR) · Bethesda, Maryland
- Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)Recruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Optimizing Ultrasound-induced Anti-inflammation in Human SubjectsRecruiting · University of Virginia · Charlottesville, Virginia